“Title: A 39-week intravenous infusion toxicity study in male cynomolgus monkeys with an 8-week recovery period”
✓ VerifiedFDA pharmacology/toxicology review, p. 64Source ↗
Pivotal GLP studies
12-wk IV and 26-wk SC mouse; 12-wk IV and 39-wk IV infusion monkey; 10-wk IV juvenile rat
“Toxicology: 12- and 26-week studies in mouse; 12- and 39-week studies in monkey; 4- and 10-week toxicity study in juvenile rat.”
✓ VerifiedFDA pharmacology/toxicology review, p. 4Source ↗
Route in tox
IV (bolus/30-min infusion); SC for 26-week mouse after IV study failed on injection-site reactions
“Golodirsen was administered by weekly injection for 12 weeks (0, 12, 120, or 960 mg/kg IV) or 26 weeks (0, 120, 300, or 600 mg/kg SC); recovery periods were 4 and 8 weeks, respectively.”
✓ VerifiedFDA pharmacology/toxicology review, p. 6Source ↗